LENZ Therapeutics, Inc.

LENZNASDAQHealthcare● Active

$6.79

$-0.22(-3.08%)

Market Cap$213034295

P/E Ratio—

52W High$50.4

52W Low$6.61

Avg Volume936K

Open$7.09

Beta1.47

Insider Trades Ownership Employees

LENZ Therapeutics, Inc. (LENZ) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LENZ · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.08

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 8%Active transactions only · RSU vesting excluded92% Sell ↓

LENZ Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

LENZ insider buying and selling by quarter

LENZ insider selling · LENZ insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

7.7M3.9M0

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · LENZ ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

LENZ executive sell shares · LENZ board member insider trading · LENZ insider trading SEC filing

Showing 56 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Mar 27, 2026	George Jeffrey P. Director	Purchase	5,592	$8.92	$50K	5,592	Form 4
Mar 27, 2026	Schimmelpennink Evert B. President, CEO and Secretary · Director	Purchase	28,089	$8.95	$251K	77,289	Form 4
Mar 27, 2026	Chevallard Daniel R. CFO	Purchase	7,500	$8.57	$64K	12,886	Form 4
Nov 17, 2025	Olsson Shawn Chief Commercial Officer	Option	10,000	$2.08	$21K	14,733	Form 4
Nov 17, 2025	Olsson Shawn Chief Commercial Officer	Sale	4,212	$25.74	$108K	10,521	Form 4
Nov 17, 2025	Olsson Shawn Chief Commercial Officer	Sale	5,788	$26.37	$153K	4,733	Form 4
Nov 7, 2025	MCCOLLUM JAMES W Director	Purchase	10,500	$22.79	$239K	10,500	Form 4
Nov 7, 2025	Chevallard Daniel R. CFO	Purchase	2,178	$22.76	$50K	5,386	Form 4
Nov 7, 2025	Chevallard Daniel R. CFO	Purchase	20	$22.71	$454	3,208	Form 4
Sep 30, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	49,701	$45.35	$2.25M⚡	1,133,842	Form 4
Sep 30, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	83,066	$46.41	$3.85M⚡	1,050,776	Form 4
Sep 30, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	177	$47.01	$8K	1,050,599	Form 4
Sep 30, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	34,405	$45.35	$1.56M⚡	821,752	Form 4
Sep 30, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	57,502	$46.41	$2.67M⚡	764,250	Form 4
Sep 30, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	123	$47.01	$6K	764,127	Form 4
Sep 18, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	49,479	$41.59	$2.06M⚡	1,224,718	Form 4
Sep 18, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	40,907	$43.00	$1.76M⚡	1,183,811	Form 4
Sep 18, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	268	$43.30	$12K	1,183,543	Form 4
Sep 18, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	24,370	$41.59	$1.01M⚡	876,437	Form 4
Sep 18, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	20,148	$43.00	$866K	856,289	Form 4
Sep 18, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	132	$43.30	$6K	856,157	Form 4
Aug 22, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	20,493	$40.03	$820K	1,379,727	Form 4
Aug 22, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	5,668	$40.59	$230K	1,374,059	Form 4
Aug 25, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	50,270	$39.53	$1.99M⚡	1,323,789	Form 4
Aug 25, 2025	Versant Venture Capital VI, L.P. 10 percent owner	Sale	2,149	$39.92	$86K	1,321,640	Form 4

George Jeffrey P.

Director

Purchase

Date

Mar 27

5,592

Price

$8.92

Value

$50K

View Form 4 on SEC.gov

Schimmelpennink Evert B.

President, CEO and Secretary · Director

Purchase

Date

Mar 27

28,089

Price

$8.95

Value

$251K

View Form 4 on SEC.gov

Chevallard Daniel R.

CFO

Purchase

Date

Mar 27

7,500

Price

$8.57

Value

$64K

View Form 4 on SEC.gov

Olsson Shawn

Chief Commercial Officer

Option

Date

Nov 17

10,000

Price

$2.08

Value

$21K

View Form 4 on SEC.gov

Olsson Shawn

Chief Commercial Officer

Sale

Date

Nov 17

4,212

Price

$25.74

Value

$108K

View Form 4 on SEC.gov

Olsson Shawn

Chief Commercial Officer

Sale

Date

Nov 17

5,788

Price

$26.37

Value

$153K

View Form 4 on SEC.gov

MCCOLLUM JAMES W

Director

Purchase

Date

Nov 7

10,500

Price

$22.79

Value

$239K

View Form 4 on SEC.gov

Chevallard Daniel R.

CFO

Purchase

Date

Nov 7

2,178

Price

$22.76

Value

$50K

View Form 4 on SEC.gov

Chevallard Daniel R.

CFO

Purchase

Date

Nov 7

Price

$22.71

Value

$454

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 30

49,701

Price

$45.35

Value

$2.25M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 30

83,066

Price

$46.41

Value

$3.85M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 30

177

Price

$47.01

Value

$8K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 30

34,405

Price

$45.35

Value

$1.56M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 30

57,502

Price

$46.41

Value

$2.67M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 30

123

Price

$47.01

Value

$6K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 18

49,479

Price

$41.59

Value

$2.06M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 18

40,907

Price

$43.00

Value

$1.76M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 18

268

Price

$43.30

Value

$12K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 18

24,370

Price

$41.59

Value

$1.01M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 18

20,148

Price

$43.00

Value

$866K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Sep 18

132

Price

$43.30

Value

$6K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Aug 22

20,493

Price

$40.03

Value

$820K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Aug 22

5,668

Price

$40.59

Value

$230K

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Aug 25

50,270

Price

$39.53

Value

$1.99M ⚡

View Form 4 on SEC.gov

Versant Venture Capital VI, L.P.

10 percent owner

Sale

Date

Aug 25

2,149

Price

$39.92

Value

$86K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LENZ insider trading

LENZ insider trades

LENZ Therapeutics, Inc. (LENZ) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Versant Venture Capital VI, L.P. (10 percent owner), Chevallard Daniel R. (CFO), Olsson Shawn (Chief Commercial Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. LENZ insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For LENZ Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

LENZ insider trading · 5 questions

The insiders of LENZ Therapeutics, Inc. (LENZ) include executives and directors such as Versant Venture Capital VI, L.P. (10 percent owner), Chevallard Daniel R. (CFO), Olsson Shawn (Chief Commercial Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LENZ board member insider tradingwho are LENZ insidersLENZ insider rosterLENZ Therapeutics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026